April 24, 2014 - Entera's drug for the treatment of hypoparathyroidism has been approved as an orphan drug by the U.S. Food and Drug Administration (FDA).
Innovative Technology Platform
Entera's innovative technology enables oral drug delivery of large molecules
Pipeline of Drug Development
Entera conducts clinical trials of three oral drugs based on a proven active compound
Experienced Management Team
The managers of Entera have more than 50 years of experience in drug development